Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Pioneering biotech spin-out set to boost the use of the stem – cell technology in human medicine

13.11.2006
VetCell, a British biotechnology spin-out from the Royal Veterinary College (RVC) that has pioneered the use of stem cell technology to treat tendinitis in racehorses, is set to launch in America. Moreover, the pioneering biotech firm is set to boost the use of the technology in human medicine.

The London-based company has developed a technique that uses stem cells drawn from the umbilical cord blood of foals or from adult horses’ bone marrow, to treat muscular injuries to horse’s leg tendons.

Some of the most devastating injuries and diseases of performance horses are now treatable thanks to high tech stem cell therapy. Chronic tendinitis continues to be one of the most common career-limiting injuries suffered by flat racing and jump horses. Three high-profile horses — Harchibald, Inglis Drever and Kicking King — missed this year’s Cheltenham Festival because of tendon problems. Stem cells, for the first time, offer the prospect of a return to a fully functional tendon.

Set up by researchers at the RVC in 2002 the spin-out has seen demand for its service grow rapidly and the company is currently treating about 30 horses per month for a fee of up to £2,000 per animal.

... more about:
»Spin-out »Stem »Technology »injuries

David Mountford, VetCell’s Chief Executive, said: “Tendinitis is a leading cause of retirement for racehorses that the traditional veterinary profession has had a lot of difficulty treating. The treatment, which involves injecting cultured horse stem cells directly into the damaged muscle, is twice as effective as conventional therapies for muscular injuries to racehorses, which are often valued in the millions of pounds.”

The company already has customers throughout Europe and the Middle East and has licensed the technology for use in Japan, Australia, Argentina and South Africa. The therapy allows the muscles to heal without the usual scarring and lesions, which lead to stiffness and a propensity to further injury.

Now the company is using its expertise to set its sights on a potentially revolutionary stem-cell-based treatment for human shoulder injuries that, if successful, could be worth billions of pounds.

The company is developing trials for a treatment for similar (rotator cuff) injuries in human beings, in partnership with the Institute of Orthopaedics and Musculoskeletal Science. Currently, about 60 per cent of elderly people in the UK experience shoulder-related injuries.

For more information and interviews contact : Jenny Murray, Communications Management, Tel: 01727 733 889, Email: jenny@communicationsmanagement.co.uk

Jenny Murray | alfa
Further information:
http://www.communicationsmanagement.co.uk

Further reports about: Spin-out Stem Technology injuries

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>